Hans Johan Hekland • 1958 • Bønes • 16 roles • 8 shareholdings

This website uses cookies to enhance the user experience.

||

Roles

Management

Name	Role	Total operating income	Total equity	Shares
S SARSIA VENTURE MANAGEMENT AS	Managing Director/CEO	2,501,129	163,563	25 % indirectly
H HANNIBAL INVEST AS	Managing Director/CEO	-	7,636,822	25 % directly

Boards

Name	Role	Total operating income	Total equity	Shares
S SARSIA VENTURE MANAGEMENT AS	Chairman	2,501,129	163,563	25 % indirectly
H HANNIBAL INVEST AS	Chairman	-	7,636,822	25 % directly
C COLOALERT AS	Chairman	-	3,864,575	8.33 % indirectly
S SEA-HAWK NAVIGATION AS	Chairman	5,950,408	1,210,078	8.3 % indirectly
U UNI TARGETING RESEARCH AS	Board Member	2,523,951	2,480,972	8.22 % indirectly
E EUROPEAN ONCOLOGY LAB AS	Chairman	93,500	-27,130	8.22 % indirectly
S SCREENCANCER AS	Chairman	8,007,188	5,364,101	-
N NORDA ASA	Board Member	169,611,794	318,543,534	-
D DEEPX ANALYTICS AS	Chairman	-	-11,278	-
D DEEPX HEALTH AS	Board Member	792,936	141,278,563	-
B BALTER MEDICAL AS	Chairman	4,323,743	-9,383,888	-
L LIFECARE ASA	Board Member	11,028,000	-8,761,000	-
R REMOVAID AS	Board Member	145,113	-5,784,651	-
D DEEPX AQUA AS	Chairman	-	51,340	-

Last update: Jun 12, 2025

Related industries3

Direct relationships5

Shares owned by Hans Johan Hekland

Name	Share class	Total operating income	Total equity	Share
H HANNIBAL INVEST AS	A-aksjer	0	7,636,822	25 % directly
S SARSIA VENTURE MANAGEMENT AS		2,501,129	163,563	25 % indirectly
C COLOALERT AS		0	3,864,575	8.33 % indirectly
S SEA-HAWK NAVIGATION AS		5,950,408	1,210,078	8.3 % indirectly
E EUROPEAN ONCOLOGY LAB AS		93,500	-27,130	8.22 % indirectly
U UNI TARGETING RESEARCH AS		2,523,951	2,480,972	8.22 % indirectly
E EPSIS AS		22,520,776	18,035,514	1.74 % indirectly
S SARSIA DEVELOPMENT AS Closed		0	-5,227,124	1.46 % indirectly

Limited to direct ownership positions of 0.5% or more.

Last update: Jun 2, 2025